VolitionRx Ltd
VNRX
10 hedge funds and large institutions have $3.66M invested in VolitionRx Ltd in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.25% more ownership
Funds ownership: 0% → 0.25% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Southpoint Capital Advisors
New York
|
+$3.31M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$82.8K |
| 3 |
SIM
Spark Investment Management
New York
|
+$72.9K |
| 4 |
GBA
Garrison Bradford & Associates
New York
|
+$64.2K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$49.5K |
Top Sellers
VNRX Hedge Fund Activity: Q1 2015 in Review
10 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2015, worth a combined $3.66M.
Buyers outnumbered sellers: 10 funds opened new VNRX positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Southpoint Capital Advisors, opening a new position worth an estimated $3.31M.
- 10 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $3.66M of VolitionRx Ltd stock for Q1 2015.
- 10 funds opened new VolitionRx Ltd positions in Q1 2015 and 0 closed out, a net change of +10 holders.
- The largest VolitionRx Ltd buyer in Q1 2015 was Southpoint Capital Advisors, an estimated $3.31M added.
Based on aggregated 13F filings for Q1 2015.